Search

everythinglearnresearchcommunity

for

Search:↓

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

Anticoagulant therapy may cause hair loss, especially in women, and stopping the medication can lead to hair regrowth.

Epidermal growth factor helps hair regrow after chemotherapy.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Low-intensity ultrasound may prevent hair loss during taxane chemotherapy.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

The document suggests a possible link between hair loss and thyroid cancer, but doesn't provide definite proof.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Hair transplant worked for a patient with a specific scalp condition after breast cancer chemotherapy.

Boosting certain cell signals can prevent hair loss from chemotherapy and radiation.

Combined therapy effectively improved severe alopecia areata in all patients after 6 months.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

The combined treatment helped prevent hair loss and promoted full hair regrowth in breast cancer patients after chemotherapy.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

Scalp cooling significantly reduces chemotherapy-induced hair loss.

Cytotoxic T cells cause hair loss in chronic alopecia areata.